FDA to authorize Novavax’s Covid-19 vaccine – POLITICO

Novavax, a biotech company headquartered in Maryland, still needs to complete a final round of quality testing for its vaccine over the next several days. But the Biden administration earlier this week purchased 3.2 million doses of the vaccine in anticipation of the shot soon receiving a green light from the agency.

The expected authorization comes after two years of setbacks for Novavax, once considered among the most promising Covid vaccine developers. The Trump administration in 2020 went as far as pre-ordering 110 million doses of the vaccine, investing $1.6 billion in the process.

Source: FDA to authorize Novavax’s Covid-19 vaccine – POLITICO